awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33398716-D8F8901A-48ED-427F-844E-C21263483115
Q33398716-D8F8901A-48ED-427F-844E-C21263483115
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398716-D8F8901A-48ED-427F-844E-C21263483115
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).
P2860
Q33398716-D8F8901A-48ED-427F-844E-C21263483115
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398716-D8F8901A-48ED-427F-844E-C21263483115
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70ea8e210af34c6411d5127994a1b7f507d6f4ac
P2860
Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors.